Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer - Wikidata - wikimedia - TriplyDB

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer

http://www.wikidata.org/entity/Q33863328

about

Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3 Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer.Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.Expression of phosphatase of regenerating liver-3 is associated with prognosis of Wilms' tumor.The regulatory roles of phosphatases in cancer.The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration.Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis.Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.PRL‑3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients.Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration.A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesion

P2860

Q24318418-1E9D593F-4AE5-42C6-821A-20342997439A Q28066318-7756055A-EFAB-451D-9137-86C418745DE9 Q30420119-1B686064-B870-4A99-8745-B4D03F87D381 Q35034895-37916F06-E009-4353-BABE-547A709D4F7E Q37587207-622AD997-77B2-4DBA-A496-43DC9D33354F Q38090432-2CE0A095-9DF0-427E-B492-7C0060EC305E Q38781568-9C6C4139-9E04-4E8B-8806-57CC67369CE0 Q38786529-2368EA5C-B848-40B7-BB1F-8F03A044C3C8 Q41127993-13F5D9E9-4049-44B4-BBB4-006291A7E6CE Q43678272-BE05442B-1360-40C7-8F94-21D1097FA0BF Q47104255-8E6BE650-0870-45EE-9D66-58347434ADB5 Q52590705-67EB9896-198F-42AD-B453-96209D873429 Q56375935-A2E82E4A-BE6F-4535-B96B-A424AAF0D6AC

P2860

Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer

http://www.wikidata.org/entity/Q33863328

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Therapeutic potential of PRL-3 ...... mplification in gastric cancer

@ast

Therapeutic potential of PRL-3 ...... mplification in gastric cancer

@en

type

label

Therapeutic potential of PRL-3 ...... mplification in gastric cancer

@ast

Therapeutic potential of PRL-3 ...... mplification in gastric cancer

@en

prefLabel

Therapeutic potential of PRL-3 ...... mplification in gastric cancer

@ast

Therapeutic potential of PRL-3 ...... mplification in gastric cancer

@en

P1433

Q33863328-D50792F5-C93F-44E4-BBAB-95016F4A849B

P1476

Q33863328-E0A90278-4DA2-4F46-BAEA-76A385072A47

P2093

Q33863328-02CB1632-58B2-4135-8476-EA1A364B012B

Q33863328-10FE4BD0-81E2-420E-9D60-52B5F323CC59

Q33863328-377D399B-BEF3-46DF-91D2-A336A6B25BB7

Q33863328-482C2321-2F34-404C-97BC-A182940F4BCD

Q33863328-4CA1AFC5-A17E-4AE9-8CB2-D05E570D5438

Q33863328-53D2E597-32C0-456F-B070-81004E82198D

Q33863328-AFBCB611-6229-496D-B1CB-3BA5C5710E2E

Q33863328-BDC97923-BD86-4968-95EB-7BF982ABD61D

Q33863328-DC3072D4-ADFC-462A-B243-2806B75CEBF2

Q33863328-EDDF204C-4510-4C85-A289-E6D2A26046DC

P2860

Q33863328-0DE740A1-0CA2-42D2-B0CF-EE625106B88F

Q33863328-1068C159-C5B6-41F9-8D8E-EB8160A1CF92

Q33863328-10FD177E-E8C0-41C0-9819-7BAA0A60C889

Q33863328-1D68B969-BE48-41E2-9C65-263DDE713535

Q33863328-21B67158-9A73-4939-8AB2-1F4F162BE883

Q33863328-28355D72-B3BE-4F95-A7C4-578BC2A29D50

Q33863328-2D36EC20-FFB4-4A45-8880-2E46781FB823

Q33863328-385C3D43-A20E-4B36-AB64-43C3DA0A89FB

Q33863328-4105A8B2-C116-49D5-8FBE-DF3EDC192868

Q33863328-4BA8540B-FC3D-45D3-B537-7D13FF93798D

P2888

Q33863328-FD7E552B-7F1F-4E11-95B3-069ECFF107D3

P304

Q33863328-D95B11F2-0535-4E47-8D5C-15CC34AB72E5

P31

Q33863328-7B2D78C4-04AC-480A-BB56-E20C2AE7417A

P356

Q33863328-A2B71199-4D23-4068-8261-7C93FAEDB740

P407

Q33863328-158B8796-1764-48DD-8038-A239262E1BBC

P478

Q33863328-C5DAC756-BB76-4BE9-8C02-D28AA8485C8C

P577

Q33863328-CBA995F9-0F96-44C7-B9F1-5FD82B3BAD25

P5875

Q33863328-04E6E0DD-AF8E-4019-A2B2-68F3A7B035F6

P6179

Q33863328-35B1B732-ECF2-4B66-9644-809D40A6C843

P698

Q33863328-90AAA6E9-C8EC-46BA-9719-610A048546EF

P932

Q33863328-94FB04CC-D393-4A54-84B7-6A4D6DB7E360

P356

1471-2407-11-122

P1433

P1476

Therapeutic potential of PRL-3 ...... mplification in gastric cancer

@en

P2093

Akira Ooki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kawamata

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nishimiya

http://www.w3.org/2001/XMLSchema#string

Kazunori Nakamura

http://www.w3.org/2001/XMLSchema#string

Keishi Yamashita

http://www.w3.org/2001/XMLSchema#string

Masahiko Watanabe

http://www.w3.org/2001/XMLSchema#string

Mina Waraya

http://www.w3.org/2001/XMLSchema#string

Natsuya Katada

http://www.w3.org/2001/XMLSchema#string

Shinichi Sakuramoto

http://www.w3.org/2001/XMLSchema#string

Shiro Kikuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Prenylation-dependent association of protein-tyrosine phosphatases PRL-1, -2, and -3 with the plasma membrane and the early endosome

Role of PRL-3, a human muscle-specific tyrosine phosphatase, in angiotensin-II signaling

A phosphatase associated with metastasis of colorectal cancer

PRL-3 and PRL-1 promote cell migration, invasion, and metastasis

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION

Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo

PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.

Epidemiology of gastric cancer.

Molecular characteristics of eight gastric cancer cell lines established in Japan.

P2888

1471-2407-11-122

P304

122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-122

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51019554

http://www.w3.org/2001/XMLSchema#string

P6179

1036900772

http://www.w3.org/2001/XMLSchema#string

P698

21466710

http://www.w3.org/2001/XMLSchema#string

P932

3080833

http://www.w3.org/2001/XMLSchema#string